AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn’s Disease

By afschroeder • November 23, 2025

Scott FI, Ananthakrishnan AN, Click B, Agrawal M, Syal G, Haydek JP, Yuan Y, Kappelman MD, Lewis JD, Singh S. AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease. Gastroenterology. 2025 Dec;169(7):1397-1448. doi: 10.1053/j.gastro.2025.09.038. PMID: 41274746.

Tags: Digestive Diseases, Evidence Synthesis, inflammatory bowel disease, Network meta-analysis, Positioning, Publications

Rates and Factors Associated With Hepatocellular Carcinoma Diagnosis, Stage, Treatment, and Survival

Ioannou GN, Yakovchenko V, Taddei T, Monto A, Patton H, Merante M, Spoutz P, Chia L, Yudkevich J, Aytaman A, Rabiee A, John B, Blechacz[...]

The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease

Kim SG, Zhao MY, Lam C, Jacobs JP. The Current Landscape of Microbial Biomarkers in Gastrointestinal Disease. Gastroenterol Clin North Am. 2026 Mar;55(1):165-184. doi: 10.1016/j.gtc.2025.10.003.[...]

Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use

Guan M, Chang L. Biomarkers in Irritable Bowel Syndrome: Rationale and Practical Use. Gastroenterol Clin North Am. 2026 Mar;55(1):91-105. doi: 10.1016/j.gtc.2025.08.002. Epub 2025 Oct 21.[...]